| 영문 | Rorschach Test | 한글 | 로르샤하 검사 |
|---|---|---|---|
| 설명 | 사고장애와 정서장애에 민감한 투사검사(projective test). 검은색과 몇가지 색으로 이루어진 잉크얼룩같은 도형이 그려진 10개의 카드를 이용한다. 피검자에게 카드를 보이고 본 것에 대해 말하도록 한다. 다음에는 얼룩의 어느 위치가 피검자가 말한 지각대상을 암시하는지 찾도록 한다. 피검자의 답변을 분석하면 그의 사고와 정서상태에 대한 정보를 얻을 수 있다. |
||
| 영문 | Mantoux test | 한글 | 망토우검사 |
|---|---|---|---|
| 설명 | 소아에 주로 실시하는 검사 방법으로, BCG접종후에나 혹은 결핵균에 한번이라도 노출된 경우에 양성반응으로 나온다. 우리나라에서는 생후 1개월에 BCG예방접종을 시행하므로 대부분 양성으로 나오게 되나, 이 예방접종을 받지 않은 상태에서 양성으로 나오면, 결핵균의 침투를 의심할 수 있다. |
||
| 영문 | stress test | 한글 | 스트레스 검사 |
|---|---|---|---|
| 설명 | 협심증이 일어나기 쉬운 환자에게서 그 정도를 판단하기위해 시행한다. 방법은 같은 곳에서 환자를 달리도록 한 다음, 얼마의 속도에서 혈압이 떨어지고 협심증 증상이 나타나는가를 검사한다. 대개 심할수록 낮은 속도에서도 증상이 빨리 나타난다. |
||
| 영문 | visual field test | 한글 | 시야검사 |
|---|---|---|---|
| 설명 | 눈을 한곳에 고정시킨 채, 관찰할 수 있는 주변공간을 시야라 한다. 시야를 검사하는 가장 간단한 방법은 대면검사(confronting test)이다. 이것은 피검사자의 눈을 검사자의 눈에 맞추어 보도록 하여 눈을 고정시킨채, 검사자가 손가락끝을 위쪽, 아래쪽, 왼쪽, 오른쪽, 그리고 비스듬히 경사진 곳 등으로 옮겨보아 피검사자가 관찰할 수 있는지 여부를 정하는 검사법이다. 이보다 정확한 검사법은 자동식 컴퓨터시야검사법이 있다. 대개, 눈자체의 이상이 있어도 시야검사에서 이상이 나오지만, 이외 뇌의 이상으로 시각의 형성경로에 이상이 있어도 역시 이상소견을 보인다. |
||
| 영문 | Draw a person test | 한글 | 인물화 성격검사 |
|---|---|---|---|
| 설명 | 인물화 성격검사는 처음에는 지능검사로 개발되었고, 그 후에는 사람의 무의식의 요소를 검사하는 방법으로 발전하였다. 검사재료는 지우개가 있는 연필과 백지를 피검자에게 주고, 사람을 그려보라는 지시를 하며, 검사자는 그리는 순서와 평가를 기록하고, 다 그린 후에는 먼저와 다른 이성을 그리도록 한다. 이 검사에서의 신체의 모양은 곧 자아상을 반영한다는 입장, 그림에서 강조된 기관은 의사소통수단, 관념화, 욕구체계, 성적 능력, 갈등, 좌절경험, 성장력 등을 반영한다고 한다. 이것은 아동과 성인에게 개별적 또는 집단적으로 실시할 수 있고, 간편하면서도 유익한 것이다. 임상적으로는 뇌의 기질적 변화를 알아내기 위한 목적으로도 많이 이용된다. |
||
| CAT | California Achievement Test; capillary agglutination test; catalase; cataract; catecholamine; Childr... |
|---|---|
| TAT | tetanus antitoxin; thematic apperception test; thematic aptitude test; thrombin-antithrombin complex... |
| Bz-Ty-PABA test | N-Benzoyl-L-Tyrosyl-p-Amino-Benzoic Acid test = Bentiromide test = Tr... |
| DAT | delayed-action tablet; dementia Alzheimer's type; dental aptitude test; diacetylthiamine; diet as to... |
| IT | immunological test; immunotherapy; implantation test; individual therapy; information technology; in... |
| influenza | An acute viral infection involving the respiratory tract, occurring in isolated cases, in epidemics or in pandemics striking many continents simultaneously or in sequence. It is marked by inflammation of the nasal mucosa, the pharynx and conjunctiva and by headache and severe, often generalised myalgia. Fever, chills and prostration are common. Involvement of the myocardium and of the central nervous system occur infrequently. A necrotising bronchitis and interstitial pneumonia are prominent features of severe influenza and account for the susceptibility of patients to secondary bacterial pneumonia due to Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus. The incubation period is one to three days and the disease ordinarily lasts for three to ten days. Influenza is caused by a number of serologically distinct strains of virus, designated A (with many subgroups), B and C. Synonym: flu, grippe. (18 Nov 1997) |
|---|---|
| influenza a | A particular genus of influenza virus. Prone to genetic variability, the influenza vaccine must be updated annually. Symptoms of influenza include fever, muscle aches, headache, malaise, chills, cough and sore throat. (27 Sep 1997) |
| influenza a virus | The type species of the genus influenzavirus a, b that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is by aerosol (human and most non-aquatic hosts) or waterborne (ducks). (12 Dec 1998) |
| influenza a virus, avian | Strains of influenza a virus causing influenza in birds. Transmission is caused by close contact or is waterborne in aquatic species. (12 Dec 1998) |
| influenza a virus, human | Strains of influenza a virus causing influenza and sometimes pneumonia in humans. Transmission is by aerosol. (12 Dec 1998) |
| influenza a virus, porcine | Strains of influenza a virus causing influenza and pneumonia in domestic pigs. (12 Dec 1998) |
| influenza B | Influenza caused by strains of influenza virus type B; outbreaks are usually more limited than those due to influenza virus type A, although infections by the two types are clinically indistinguishable; occasionally associated with Reye's syndrome. (05 Mar 2000) |
| influenza bacillus | <bacteria> Bacterium sometimes associated with influenza virus infections, causes pneumonia and meningitis. (18 Nov 1997) |
| influenza b virus | Species of the genus influenzavirus a, b that cause influenza and other diseases in humans only. Antigenic variation is less extensive than in type a viruses (influenza a virus) and consequently there is no basis for distinct subtypes or variants. Epidemics are less likely than with type a and there have been no pandemics. (12 Dec 1998) |
| influenza C | Influenza caused by strains of type C influenza virus; the disease is milder than that caused by types A and B and has become uncommon in recent years. (05 Mar 2000) |
| influenza meningitis | <pathology> A form of meningitis caused by the bacterium haemophilus influenza. Inflammation of the membranes (meninges) covering the brain and spinal cord can result after infection with this organism. Influenza meningitis occurs most frequently in children under 5 years old. Onset may be sudden or occur more slowly after an upper respiratory infection. Symptoms and features include fever, headache, stiff neck, photophobia and mental status changes. Infants may be irritable and exhibit poor feeding associated with fever. Severe cases may progress to seizures, coma and death. Treatment always includes high-dose systemic antibiotics and corticosteroids may also be used in some select cases. (27 Sep 1997) |
| influenza nostras | Influenza, usually of a less severe type, occurring with some degree of regularity during the winter season, especially in the larger cities of the world. Synonym: influenza nostras. (05 Mar 2000) |
| influenza type a | A common acute viral infection of the nasopharynx and respiratory tract which occurs in epidemic forms. A common cause is the Influenza a virus. Annual vaccination is recommended for those in high risk groups (health care workers, elderly and immunocompromised) for influenza infection. Common symptoms include runny nose, fever, weakness, headache, body aches, muscle aches, nausea and back pain. Treatment of symptoms has been successful with amantadine or rimantadine. (27 Sep 1997) |
| influenza vaccine | A special vaccine which provides immunity to infection by a variety of Influenza viruses. The vaccine is updated annually due to the constant introduction of new viral strains. Flu vaccination programs are common in the elderly population and any other groups who are at increased risk of viral infection. (27 Sep 1997) |
| influenza virus | <organism, virology> Member of the Orthomyxoviridae that causes influenza in humans. There are three types of influenza virus. Each type of virus has a stable nucleoprotein group antigen common to all strains of the type, but distinct from that of the other type; each also has a mosaic of surface antigens (haemagglutinin and neuraminidase) which characterise the strains and which are subject to variations of two kinds: 1) a rather continual drift that occurs independently within the haemagglutinin and neuraminidase antigens; 2) after a period of years, a sudden shift (notably in type A virus of human origin) to a different haemagglutinin or neuraminidase antigen. The sudden major shifts are the basis of subdivisions of type A virus of human origin. Type A causes the world wide epidemics (pandemics) of influenza and can infect other mammals and birds. Type B only affects humans. Type C causes only a mild infection. Types A and B virus evolve continuously, resulting in changes in the antigenicity of their spike proteins, preventing the development of prolonged immunity to infection. The spike proteins, external haemagglutinin and neuraminidase have been studied as models of membrane glycoproteins. Strain notations indicate type, geographic origin, year of isolation, and, in the case of type A strains, the characterizing subtypes of haemagglutinin and neuraminidase antigens (e.g., A/Hong Kong/1/68 (H3 N2); B/Hong Kong/5/72). (08 Mar 2000) |